Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lighthouse Point, FL
SEC filing record 1 source field available
Fiscal year end
31 December
ZyVersa Therapeutics, Inc. has filed 318 SEC EDGAR filings since 13 May 2021

SEC filing history

Showing 1-25 of 318 matching filings.

Per page
25
Current page
1
NT 10-Q File 001-41184

NT 10-Q

Filing date
14 Nov 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE File 001-41184

25-NSE filing

Filing date
06 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93211

SCHEDULE 13G/A filing

Filing date
14 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-288470

EFFECT filing

Filing date
06 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
01 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-288470

S-1/A

Filing date
01 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-288470

UPLOAD filing

Filing date
30 Jul 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
16 Jul 2025
Reporting date
11 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jul 2025
Reporting date
11 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jul 2025
Reporting date
11 Jul 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .